NSB

NEUROSCIEN FPO [NSB]
NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia.
Healthcare · ASX Small Cap
$0.0610 +1.7%

Updated 22 Jul 2026 · Signals refresh every scan

Get alerts when NSB triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track NSB — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Above-average volume (1.7x) on a red day — sellers in control
  • Drifting lower — down 7.6% over the last 5 days
  • Strong cash runway (18 quarters)
  • Very high P/S ratio (73.6x)
  • Strong revenue growth (+129%)
  • Near 52-week low (2% of range)
  • Small-cap ($20-100M)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 61% over the past year
  • Revenue growing at +129% — the top line is moving in the right direction
  • Altman Z-Score grey zone (1.94, low-confidence approx)
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-1.15%/day)
Ask Scout AI about NSB
"What's driving NSB today?" "How does NSB compare to peers?" "Key risks for NSB?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE StemSmart Presentation - ISCT ANZ 2026
NONE Notification of cessation of securities - NSB
NONE Escrowed Securities Update

Recent ASX Announcements

2026-07-21 StemSmart Presentation - ISCT ANZ 2026
2026-06-30 Notification of cessation of securities - NSB
2026-06-19 Escrowed Securities Update
2026-06-11 Investor Webinar
2026-06-08 Change in substantial holding

Key Metrics

$23.4M
Market Cap
254K
Avg Volume
1.7x
Vol Ratio
$0.06 — $0.26
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-29.6%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 54%
LLeader vs LaggardlaggardRS: -21
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

101 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
IDT +28.1%ADR +27.3%LDX +23.8%EYE +17.4%ECS -16.7%
Compare:NSB vs IDTNSB vs ADRNSB vs LDX
Scout Pro — Deeper Analysis for NSB
Try Pro free for 30 days
Share this analysis

Track NSB and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required